First-pass extracted concept

CAR-M

Candidate: concept label2 source documents1 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

CAR-M is described as a macrophage-based CAR platform. The abstract presents it as part of next-generation expansion beyond T-cell-based CAR therapies.

Source 2DOI PubMed

Evidence Snippets

The web research summary states that a 2025 Frontiers review on engineered cell therapies for autoimmune diseases explicitly discusses CAR-M alongside CAR-T.

Evidence 1Source 1DOI PubMedprovenance

expanding CAR platforms to include other immune effector cells, such as natural killer cells (CAR-NK) and macrophages (CAR-M)

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 0 linked claims

Source 2primary paper2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1next generation strategysupports2025Source 2DOI PubMed

Novel approaches under development to overcome CAR-T barriers include in vivo CAR-T generation, logic-gated CAR systems, and expansion to CAR-NK and CAR-M platforms.